These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33922338)

  • 41. Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.
    Miszta P; Jakowiecki J; Rutkowska E; Turant M; Latek D; Filipek S
    Methods Mol Biol; 2018; 1705():265-296. PubMed ID: 29188567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining fragment docking with graph theory to improve ligand docking for homology model structures.
    Sarfaraz S; Muneer I; Liu H
    J Comput Aided Mol Des; 2020 Dec; 34(12):1237-1259. PubMed ID: 33034007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterizing common substructures of ligands for GPCR protein subfamilies.
    Erguner B; Hattori M; Goto S; Kanehisa M
    Genome Inform; 2010; 24():31-41. PubMed ID: 22081587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in structure-based virtual screening of G-protein coupled receptors.
    Ananthan S; Zhang W; Hobrath JV
    AAPS J; 2009 Mar; 11(1):178-85. PubMed ID: 19291412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galaxy7TM: flexible GPCR-ligand docking by structure refinement.
    Lee GR; Seok C
    Nucleic Acids Res; 2016 Jul; 44(W1):W502-6. PubMed ID: 27131365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.
    Urmi KF; Finch AM; Griffith R
    J Mol Graph Model; 2017 Sep; 76():488-503. PubMed ID: 28818718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SPOT-Ligand: Fast and effective structure-based virtual screening by binding homology search according to ligand and receptor similarity.
    Yang Y; Zhan J; Zhou Y
    J Comput Chem; 2016 Jul; 37(18):1734-9. PubMed ID: 27074979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
    Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
    Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.
    Szwabowski GL; Griffing M; Mugabe EJ; O'Malley D; Baker LN; Baker DL; Parrill AL
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
    Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.